Mucociliary and cough clearance as a biomarker for therapeutic development

Area of Science:

• Pulmonary Physiology
• Biomarker Development
• Respiratory Medicine

Background:

• Mucociliary and Cough Clearance (MCC/CC) are critical physiological processes for maintaining airway health.
• The utility of MCC/CC as a biomarker for disease progression and therapeutic intervention is increasingly recognized.
• Accurate measurement of MCC/CC is essential for evaluating novel therapies targeting airway secretions.

Purpose of the Study:

• To discuss and optimize methods for measuring MCC/CC.
• To explore the application of MCC/CC as a biomarker in therapeutic development for lung diseases.
• To consolidate knowledge on in vivo human MCC/CC measurement techniques.

Main Methods:

• A workshop focused on "Mucociliary and Cough Clearance (MCC/CC) as a Biomarker for Therapeutic Development" was convened.
• Presentations detailed current in vivo human MCC/CC measurement methodologies.
• Discussions involved researchers, pharmaceutical companies, and clinicians interested in MCC/CC assessment.

Main Results:

• Key methodologies for in vivo human MCC/CC measurement were presented and discussed.
• The potential for MCC/CC to serve as a reliable biomarker for therapeutic efficacy was highlighted.
• Areas for optimization and standardization of MCC/CC measurement techniques were identified.

Conclusions:

• Standardized and optimized MCC/CC measurement methods are vital for advancing therapeutic development in respiratory diseases.
• MCC/CC holds significant promise as a biomarker for assessing the effectiveness of muco-active therapies.
• Further research and collaboration are needed to fully leverage MCC/CC in clinical practice and drug development.